Möchten Sie immer auf dem neuesten Stand bleiben?

Global humanitarian charity Human Appeal has launched the “Hajj 10K Steps Challenge,” running from May 17–26, 2026, to coincide with the Hajj pilgrimage.

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451 Continued progress toward starting SC451 Phase 1 trial later...

Net Revenue increased 4.5% to $312.0 millionGAAP Net Income increased 188.6% to $1.4 millionAdjusted Net Income decreased 3.6% to $3.4 millionAdjusted EBITDA increased 3.8% to $ $10.1 million LAS...

Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected mid-2026IND clearance of ARR-002, ArriVent’s dual-targeting MUC16/NaPi2b tetravalent...

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

Global humanitarian charity Human Appeal has launched the “Hajj 10K Steps Challenge,” running from May 17–26, 2026, to coincide with the Hajj pilgrimage.

New York, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Presbyopia Market to Witness Accelerated Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) Supported by Expanding Treatment Landscape |...

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide,...

Durham, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- AB-1009, an adeno-associated virus (AAV) investigational gene therapy, is being evaluated for the treatment of late-onset Pompe disease (LOPD) in the...

CIPN is a common nerve-damaging side effect of chemotherapy with no FDA-approved treatment options Fast Track designation reflects the significant unmet need and enables potential accelerated drug...